Nutra Pharma Corp
OTC:NPHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nutra Pharma Corp
OTC:NPHC
|
US |
|
L
|
Lonza Group AG
XBER:LO3
|
CH |
|
I
|
I&I Group PCL
SET:IIG
|
TH |
|
M
|
Merck KGaA
F:MRK
|
DE |
|
A
|
ASR Nederland NV
SWB:A16
|
NL |
|
S
|
Synchrony Financial
F:SFE
|
US |
|
Poste Italiane SpA
OTC:PITAF
|
IT |
|
V
|
Vertex Pharmaceuticals Inc
XHAM:VX1
|
US |
|
Nippon Television Holdings Inc
OTC:NPTVF
|
JP |
|
Metro AG
F:B4B3
|
DE |
|
C
|
Citigroup Inc
BMV:C
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NPHC's stock price target?
Not Available
NPHC does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Nutra Pharma Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 9 years is 8%.